Thank You for Signing Up!

We’re thrilled to welcome you as an email subscriber. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.

Personalize Your Experience

Help us customize your content and recommendations by verifying your professional credentials with your National Provider Identifier (NPI).

Note: You’ll need to log in or create an account to save your NPI information.

Do you have an NPI number?

Choose your interests

Select topics that interest you to receive personalized recommendations and content.

Our Recently Published Articles

JCP
Adjunctive Atypical Antipsychotics in Major Depressive Disorder: A Network Meta-Analysis Perspective and Consensus Panel Discussion
Academic Highlights

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: A Network Meta-Analysis Perspective and Consensus Panel Discussion

October 23, 2026

A consensus panel report on 2 network meta-analyses comparing the efficacy, safety, and tolerability of 5 FDA-approved adjunctive atypical antipsychotics in MDD, with implications for earlier augmentation and shared…
, , , et al
PCC
Psychiatric Symptoms After Stopping a GLP-1 Agonist
Case Report

Psychiatric Symptoms After Stopping a GLP-1 Agonist

October 22, 2026

This report describes 2 cases of mood and psychotic symptoms associated with discontinuation of GLP-1 agonists.
, , , et al
PCC
Rope-Tying Behavior in Late-Life GAD
Case Report

Rope-Tying Behavior in Late-Life GAD

October 22, 2026

This case demonstrates an unusual manifestation of late-life anxiety in which voluntary physical restraint functioned as a maladaptive coping strategy during episodes of overwhelming autonomic and emotional arousal.
, , , et al
JCP
From Hospital to Outpatient Care After LAI Initiation in Bipolar Disorder: Nationwide Evidence from Taiwan
Original Research

From Hospital to Outpatient Care After LAI Initiation in Bipolar Disorder: Nationwide Evidence from Taiwan

October 21, 2026

In patients with bipolar disorder, SGA-LAI initiation was associated with a shift from acute-care utilization toward ambulatory follow-up.
, , , et al
PCC
Psychedelics in Psychiatry: A Wakeup Call
Letter to the Editor

Psychedelics in Psychiatry: A Wakeup Call

October 20, 2026

In this letter to the editor, the authors discuss the recent fast-tracking of psychedelic research in the US, noting that clinicians must now lead this renaissance with scientific rigor…
,
PCC
When Hair Becomes Hazardous
Rounds in the General Hospital

When Hair Becomes Hazardous

October 20, 2026

Trichotillomania and trichophagia are key behavioral drivers of trichobezoar formation; direct questioning about hair ingestion is essential, as patients often minimize or do not spontaneously report this behavior.
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

SSRI Discontinuation and AUD Relapse

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

Olanzapine and Mirtazapine for Cancer-Related Anorexia

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe